Metraipolis › archive › dc_ce644cb0aa87

Profiles and influencing factors of pulmonary fibrosis associated with biologic and conventional disease-modifying antirheumatic drugs for autoimmune… — Europe PMC PMID:41079719

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41079719
DOI: 10.3389/fphar.2025.1604895
License (as archived): solo-consultazione
Archived: 2026-11-09T18:23:55.977Z
SHA-256 of the archived text: 92e3c4a43145aefb13e04c164dc95006eb13d66345c6aed1c23edaaa9536449b
Stable URL of this page: https://metraipolis.com/documento/dc_ce644cb0aa87

How to cite

Profiles and influencing factors of pulmonary fibrosis associated with biologic and conventional disease-modifying antirheumatic drugs for autoimmune… — Europe PMC PMID:41079719 — Europe PMC (en), https://europepmc.org/article/MED/41079719 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ce644cb0aa87 (Metraipolis archive dc_ce644cb0aa87, sha256 92e3c4a43145aefb13e04c164dc95006eb13d66345c6aed1c23edaaa9536449b)

BibTeX

@misc{dcce644cb0aa87,
  title = {Profiles and influencing factors of pulmonary fibrosis associated with biologic and conventional disease-modifying antirheumatic drugs for autoimmune… — Europe PMC PMID:41079719},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41079719},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ce644cb0aa87; sha256 92e3c4a43145aefb13e04c164dc95006eb13d66345c6aed1c23edaaa9536449b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41079719. Agents can read the archived copy with the MCP tool read_document.